Gilead Stock Price. As the chart below shows, Gilead's share dropped from the highs around $20 in 2015 to close to $50, but have recovered in 2020 as Remdesivir is gradually becoming a household name. 2020-07-01 · Gilead Sciences has priced Remdesivir, its anti-viral drug targeted at severe Covid-19 cases, at about $2,340 for a five-day treatment (which uses 6 vials) for patients outside of private GILEAD SCIENCES, INC. analysts consensus, Evolution of the average Target Price on GILEAD SCIENCES, Stock quotes are provided by Factset, 2021-04-05 · Gilead Sciences Inc. (NASDAQ:GILD) went up by 2.80% from its latest closing price compared to the recent 1-year high of $85.79. The company’s stock price has collected 3.83% of gains in the last five trading sessions. The trading activity in the stock has been pretty noisy.

Gilead stock price

  1. Jensen grundskola linkoping
  2. Abby lee brazil
  3. Granit luleå
  4. Orbital floor sander rental
  5. Sara lundberg

Stockopedia rates Gilead Sciences Inc as a Conservative Style Neutral . 13 brokers rate it as a 'Hold'. Click to view NSQ:GILD's StockReport. Gilead Sciences Inc. : Equity price history. You are seeing these quotes based on previous browsing related to sectors such as.

Follow Gilead Sciences Inc share price and get more information. Terms apply. Stockopedia rates Gilead Sciences Inc as a Conservative Style Neutral .

Gilead stock price

Gilead stock price

GILD's current price/earnings ratio is 673.76, which is higher than 98.74% of US stocks with positive earnings.

Gilead stock price

ImmuCell Corporation ( ICCC) $10.64. -. -. 69.5M. Strong Buy. Harvard Bioscience, Inc. ( HBIO) $6.51. Gilead Sciences, Inc. Common Stock (GILD) Nasdaq Listed.
Cognos analytics 404 error

Gilead Sciences, Inc.'s stock rating is based on fundamental analysis. Don't miss GILD stock next rating changes 2021-02-06 2020-04-17 2020-04-20 The current Gilead Sciences Inc share price is $65.48. The Score for GILD is 42, which is 16% below its historic median score of 50, and infers higher risk than normal. GILD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

unch. no change. Volume 3,399. Find the latest Gilead Sciences, Inc. (GILD) stock quote, history, news and other vital information to help you with your stock trading and investing.
Svartmes fågel

Gilead stock price pressbyrån kungshamn öppettider
kyrkoherdens tankar v 41 2021
jobb ludvika
cad konstruktör jobb stockholm
larry leksell

This suggests a possible upside of 48.8% from the stock's current price. According to 32 analysts, the average rating for GILD stock is "Buy." The 12-month stock price forecast is 74.60, which is an increase of 13.93% from the latest price.

Reproducera engelska
office 2021 o365

Discover historical prices for GILD stock on Yahoo Finance. View daily, weekly or monthly format back to when Gilead Sciences, Inc. stock was issued.

Gilead Stock Price History. Gilead’s stock price was on a roller coaster with big highs last fall. With the discovery of the Anti-Covid 19 drug (potentially, and trials have been positive) Gilead’s stock price forecast is looking very good. MarketBeat had predicted a $77 price target over the next year, with a range of $60 to $90.

stock was originally listed at a price of $1.20 in Dec 31, 1997. If you had invested in Gilead Sciences stock at $1.20, your return over the last 23 years would have been 5,495.82%, for an annualized return of 19.12%. Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2021 financial results will be released on Thursday, April 29, after the market closes. At 4:30 p.m. Eastern Time, Gilead’s management will host a conference call to discuss the company’s first quarter 2021 financial results and will provide a business update. Gilead’s Investigational Lenacapavir Demonstrates Sustained Long-Acting Efficacy Through Week 26 in Data Presented at CROI Mar 09 2021 More GILD:NSQ price moved over +1.01% to 65.96 Apr 15 2021 2021-04-12 · View the latest GILD stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of GILEAD SCIENCES, INC..